Russia's Covid-19 vaccine Sputnik V is first foreign vaccine to be approved in India after the approval of Serum's Covishield and Bharat Biotech's Covaxin. With this,...
Elaborating on the group’s road map for vaccination, Kamineni said the group, which took three weeks to cross the milestone will do 10 lakh vaccinations every...
Indian regulators had granted regulatory approval or restricted use authorisation to Sputnik V on April 12. Sputnik V has an efficacy rate of 91.6 per cent....
Initially, India had received the rights for the distribution of the first 100 million doses in India but later, it was enhanced to 125 million.
Sputnik V is the only Covid vaccine other than those of Pfizer and Moderna to show an effectiveness of over 91% against Covid-19 when taken in...
Indian Ambassador to Russia, Bala Venkatesh Varma has confirmed that the first batch of Russia's Covid-19 vaccine Sputnik V will be delivered to India within the...
Russian Direct Investment Fund (RDIF) has issued a statement stating the production of the vaccine is likely to begin in early 2021.
The Hyderabad-based pharmaceutical company Dr Reddy’s Laboratories Ltd has isolated all its data centre services across the world as a ‘preventive action’ after it detected a...
Third stage trials of the Russian Sputnik V vaccine for coronavirus can begin in India within the next few weeks once the regulatory clearances are in.